R

RenovoRx
D

RNXT

0.88540
USD
0.03
(3.96%)
مغلق
حجم التداول
1,348
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
32,449,836
الأخبار المقالات

العنوان: RenovoRx

القطاع: Healthcare
الصناعة: Biotechnology
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.